Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease - Chertow, Glenn M.; Vart, Priya; Jongs, Niels; Toto, Robert D.; Gorriz, Jose Luis; Hou, Fan Fan; McMurray, John J.V.; Correa-Rotter, Ricardo; Rossing, Peter; Sjöström, C. David; Stefánsson, Bergur V.; Langkilde, Anna Maria; et al. (Journal of the American Society of Nephrology, 2021)
Keywords: Aged; Benzhydryl Compounds - therapeutic use; Cardiovascular Diseases - epidemiology; Clinical Research; Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - drug therapy; Diabetic Nephropathies - diagnosis; Diabetic Nephropathies - epidemiology; Female; Glomerular Filtration Rate; Glucosides - therapeutic use; Humans; Male; Middle Aged; Renal Insufficiency, Chronic - diagnosis; Renal Insufficiency, Chronic - epidemiology; Sodium-Glucose Transporter 2 Inhibitors - therapeutic use; stage 4 CKD; chronic kidney disease; SGLT2 inhibitor; dapagliflozin